Papers

3

Total Citations

25

H-Index

3

About

Leszek Miszczyk is a radiation oncologist and medical physicist whose research centers on advanced stereotactic radiotherapy techniques, with particular expertise in robotic radiosurgery systems, most notably the CyberKnife platform. His work has made meaningful contributions to the clinical application of stereotactic body radiotherapy (SBRT) and hypofractionated treatment regimens across a range of challenging oncological and neurovascular conditions. Miszczyk's most-cited contribution examines the dosimetric comparison between robotic radiosurgery and micro-multileaf collimator systems for treating large or critically located arteriovenous malformations — a technically demanding area where treatment precision is paramount — earning 15 citations. His subsequent clinical investigations expanded into prostate cancer management, prospectively evaluating acute toxicity of ultrahypofractionated CyberKnife-based radiotherapy in 132 patients, and into spinal metastases, assessing both efficacy and safety of stereotactic approaches in vertebral disease. Collectively, his work addresses some of the most technically complex scenarios in modern radiation oncology, helping to define safety profiles and dosimetric standards for next-generation radiotherapy systems. His research offers practical guidance for clinicians navigating the integration of robotic radiosurgery into routine clinical workflows.

Research Focus

Key Achievements

3
H-Index
3
Papers
25
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robotic radiosurgery versus micro-multileaf collimator: a dosimetric comparison for large or critically located arteriovenous malformations
15 citations · 2013
📈 Most Prolific Year: 2015 (2 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: The Maria Sklodowska-Curie National Research Institute of Oncology, World Health Organization

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago